Preparation of Carboxamides and Peptieds using N-Succinimidyl Esters
373
1H), 7.34 (t, J = 8.4 Hz, 2H), 7.18 (d, J = 8.0 Hz, 2H), 7.10 (d, J = 8.0 Hz, 2H), 6.87 (br,
1H), 4.51 (d, J = 5.6 Hz, 2H), 2.31 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 167.3, 137.0,
135.2, 134.3, 131.3, 129.2, 128.3, 127.7, 126.9, 43.7, 21.0.
N-Cyclohexyl-4-methoxybenzamide (2): mp. 158–160◦C (lit.21 158–160◦C); TLC
Rf 0.33 (50% ethyl acetate in hexane); IR (KBr): 3304, 3040, 2927, 1618, 1599, 1544,
1498, 1443, 1331, 1245, 1171 cm−1; 1H NMR (400 MHz, CDCl3): δ 7.75 (d, J = 8.8 Hz,
2H), 6.86 (d, J = 9.2 Hz, 2H), 6.34 (br, 1H), 4.00–3.88 (m, 1H), 3.81 (s, 3H), 2.03–1.94
(m, 2H), 1.77–1.68 (m, 2H), 1.67–1.58 (m, 1H), 1.44–1.10 (m, 5H); 13C NMR (100 MHz,
CDCl3): δ 166.0, 161.8, 128.5, 127.2, 113.4, 55.2, 48.5, 33.0, 25.4, 24.8.
N-Cyclohexyl-4-nitrobenzamide (3): mp. 161–163◦C (lit.22 160–161◦C); Rf 0.78
(50% ethyl acetate in hexane); IR (KBr): 3317, 3073, 2937, 1637, 1599, 1542, 1498,
1447, 1340, 1279 cm−1; 1H NMR (400 MHz, CDCl3): δ 8.28 (d, J = 8.8 Hz, 2H), 7.92 (d,
J = 8.8 Hz, 2H), 6.10 (d, J = 6.8 Hz, 1H), 4.04–3.92 (m, 1H), 2.10–2.00 (m, 2H), 1.84–1.74
(m, 2H), 1.72–1.64 (m, 1H), 1.50–1.36 (m, 2H), 1.32–1.18 (m, 3H); 13C NMR (100 MHz,
CDCl3): δ 164.6, 149.4, 140.6, 128.0, 123.7, 49.2, 33.1, 25.4, 24.8.
N-(p-Methylbenzyl)cyclohexanecarboxamide (4): mp. 137–138◦C (lit.23 138◦C);
TLC Rf 0.81 (50% ethyl acetate in hexane); IR (KBr): 3294, 3020, 2925, 1637, 1535, 1439,
1321, 1252, 1218 cm−1; 1H NMR (400 MHz, CDCl3): δ 7.13–7.01 (m, 4H), 6.29 (br, 1H),
4.31 (d, J = 5.6 Hz, 2H), 2.31 (s, 3H), 2.10 (tt, J = 3.2, 11.6 Hz, 1H), 1.87–1.60 (m,
5H), 1.50–1.36 (m, 2H), 1.30–1.10 (m, 3H); 13C NMR (100 MHz, CDCl3): δ 175.9, 136.7,
135.5, 129.1, 127.4, 45.2, 42.8, 29.5, 25.5, 20.9.
N-Phenyl Dodecanamide (5): mp. 77.5–78.5◦C (lit.24 76–78◦C); Rf 0.78 (50% ethyl
acetate in hexane); IR (KBr): 3306, 2953, 2916, 2849, 1657, 1601, 1539, 1470, 1443 cm−1
;
1H NMR (400 MHz, CDCl3): δ 7.51 (d, J = 8.0 Hz, 2H), 7.46–7.34 (br, 1H), 7.30 (t,
J = 7.8 Hz, 2H), 7.09 (t, J = 7.2 Hz, 1H), 2.34 (t, J = 7.6 Hz, 2H), 1.77–1.66 (m, 2H),
1.38–1.21 (m, 16H), 0.88 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 171.6, 138.0,
128.9, 124.1, 119.8, 37.8, 31.9, 29.6, 29.5, 29.4, 29.3, 29.2, 25.7, 22.7, 14.1.
Cbz-L-Ala-NH-CH2C6H5 (6): mp. 129–131◦C (lit.25 129–131◦C); TLC Rf 0.16 (50%
ethyl acetate in hexane); IR (KBr): 3290, 3029, 2987, 1712, 1657, 1638, 1533, 1433, 1252,
1
1061 cm−1; H NMR (400 MHz, CDCl3): δ 7.36–7.15 (m, 10H), 6.89 (br, 1H), 5.69
(d, J = 6.8 Hz, 1H), 5.10–4.90 (m, 2H), 4.42–4.20 (m, 3H), 1.35 (d, J = 7.2 Hz, 3H); 13C
NMR (100 MHz, CDCl3): δ 172.3, 156.0, 137.9, 136.0, 128.6, 128.4, 128.1, 127.9, 127.5,
127.4, 66.0, 50.5, 43.3, 18.7.
Cbz-L-Phe-NH-CH2C6H5 (7): mp. 139–140◦C (lit.26 140–144◦C); TLC Rf 0.28 (50%
ethyl acetate in hexane); IR (KBr): 3300, 3028, 2936, 1692, 1665, 1533, 1451, 1252,
1
1031 cm−1; H NMR (400 MHz, CDCl3): δ 7.34–6.94 (m, 15H), 6.83 (br, 1H), 5.89
(d, J = 6.8 Hz, 1H), 4.84 (d, J = 4.8 Hz, 2H), 4.60–4.47 (m, 1H), 4.40–4.06 (m, 2H), 2.99
(d, J = 6.8 Hz, 2H); 13C NMR (100 MHz, CDCl3): δ 170.9, 155.9, 137.5, 136.4, 136.0,
129.3, 128.4, 128.3, 128.0, 127.7, 127.5, 127.2, 126.7, 66.7, 56.2, 43.2, 38.9.
Cbz-L-Phe-L-Ala-OEt (8): mp. 122–123◦C (lit.27 121.5◦C); TLC Rf 0.75 (50% ethyl
acetate in hexane); [α]2D2 = – 0.1 (c = 1.000, chloroform); lit.27 [α]1D8 = – 19.68 (c = 2.0,
ethanol); IR (KBr): 3289, 3065, 2986, 1749, 1693, 1659, 1545, 1454, 1263 cm−1; 1H NMR
(400 MHz, CDCl3): δ 7.38–7.15 (m, 10H), 6.39 (br, 1H), 6.24 (br, 1H), 5.46–5.32 (m, 2H),
5.08 (s, 1H), 4.51–4.41 (m, 2H), 4.16 (m, 2H), 3.16–3.01 (m, 2H), 1.35–1.19 (m, 6H); 13C